Malignant peripheral nerve sheath tumor: Molecular pathogenesis and current management considerations
Journal of Surgical Oncology2008Vol. 97(4), pp. 340–349
Citations Over TimeTop 10% of 2008 papers
Abstract
Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are rare tumors that often occur in patients with neurofibromatosis 1. Surgical resection represents the mainstay of treatment. Radiation and chemotherapy have a role in selected patients with MPNST. Accurate pathologic diagnosis remains a challenge in many cases of MPNST. There are many recent advances in the understanding of the molecular pathogenesis of MPNST which represent the best opportunities to develop new strategies for management of patients with MPNST.
Related Papers
- → A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1(2012)16 cited
- Malignant peripheral nerve sheath tumor with neurofibromatosis type 1: a 2-case report and review of the literature.(2001)
- → Superficial malignant peripheral nerve sheath tumor from recurrent neurofibroma in the abdominal wall of a patient without neurofibromatosis type 1(2018)2 cited
- → Retroperitoneal Malignant Peripheral Nerve Sheath Tumor Associated with Scoliosis in Neurofibromatosis(2001)5 cited
- → Prognosis of metastatic disease in patients with and without Neurofibromatosis 1-assoicated Malignant Peripheral Nerve Sheath Tumors: A nationwide study(2022)